Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Scheinberg

Showing results (51-60 of 121) with videos related to

Pageof 13
Sort By:
Current Opinion in Hematology|July 6, 2000
Advances in immunotherapy of hematologic malignancies: cellular and humoral approachesJ G Jurcic, K Cathcart, J Pinilla-Ibarz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Antitumor activity of actinonin in vitro and in vivoY Xu, L T Lai, J L Gabrilove, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|September 28, 2001
Breakthrough of 225Ac and its radionuclide daughters from an 225Ac/213Bi generator: development of new methods, quantitative characterization, and implications for clinical useD Ma, M R McDevitt, R D Finn, et al.
Leukemia & Lymphoma|April 1, 1996
Patterns of ganglioside expression in B cell neoplasmsK P O'Boyle, K Freeman, A Kalisiak, et al.
Cancer Immunology, Immunotherapy : CII|June 1, 1993
IgM monoclonal antibody JD118 recognizes an inducible antigen target for human-complement-mediated cytotoxicity against neoplastic B cellsM S Czuczman, P Garin-Chesa, R M Lemoli, et al.
Glycoconjugate Journal|February 1, 1991
A monoclonal antibody for terminal beta-galactose. Use in analysis of glycosphingolipidsA Kalisiak, E Oosterwijk, J G Minniti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
Molecular remission induction with retinoic acid and anti-CD33 monoclonal antibody HuM195 in acute promyelocytic leukemiaJ G Jurcic, T DeBlasio, L Dumont, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|April 24, 1999
An 225Ac/213Bi generator system for therapeutic clinical applications: construction and operationM R McDevitt, R D Finn, G Sgouros, et al.
International Journal of Cancer|July 30, 1991
Monoclonal antibodies against Gal alpha 1-4Gal beta 1-4Glc (Pk, CD77) produced with a synthetic glycoconjugate as immunogen: reactivity with carbohydrates, with fresh frozen human tissues and hematopoietic tumorsE Oosterwijk, A Kalisiak, J C Wakka, et al.
International Journal of Cancer|December 2, 1991
Neutral glycosphingolipid expression in B-cell neoplasmsA Kalisiak, J G Minniti, E Oosterwijk, et al.
Pageof 13

Showing results (51-60 of 121) with videos related to

Sort By:
Pageof 13
Current Opinion in Hematology|July 6, 2000
Advances in immunotherapy of hematologic malignancies: cellular and humoral approachesJ G Jurcic, K Cathcart, J Pinilla-Ibarz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Antitumor activity of actinonin in vitro and in vivoY Xu, L T Lai, J L Gabrilove, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|September 28, 2001
Breakthrough of 225Ac and its radionuclide daughters from an 225Ac/213Bi generator: development of new methods, quantitative characterization, and implications for clinical useD Ma, M R McDevitt, R D Finn, et al.
Leukemia & Lymphoma|April 1, 1996
Patterns of ganglioside expression in B cell neoplasmsK P O'Boyle, K Freeman, A Kalisiak, et al.
Cancer Immunology, Immunotherapy : CII|June 1, 1993
IgM monoclonal antibody JD118 recognizes an inducible antigen target for human-complement-mediated cytotoxicity against neoplastic B cellsM S Czuczman, P Garin-Chesa, R M Lemoli, et al.
Glycoconjugate Journal|February 1, 1991
A monoclonal antibody for terminal beta-galactose. Use in analysis of glycosphingolipidsA Kalisiak, E Oosterwijk, J G Minniti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
Molecular remission induction with retinoic acid and anti-CD33 monoclonal antibody HuM195 in acute promyelocytic leukemiaJ G Jurcic, T DeBlasio, L Dumont, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|April 24, 1999
An 225Ac/213Bi generator system for therapeutic clinical applications: construction and operationM R McDevitt, R D Finn, G Sgouros, et al.
International Journal of Cancer|July 30, 1991
Monoclonal antibodies against Gal alpha 1-4Gal beta 1-4Glc (Pk, CD77) produced with a synthetic glycoconjugate as immunogen: reactivity with carbohydrates, with fresh frozen human tissues and hematopoietic tumorsE Oosterwijk, A Kalisiak, J C Wakka, et al.
International Journal of Cancer|December 2, 1991
Neutral glycosphingolipid expression in B-cell neoplasmsA Kalisiak, J G Minniti, E Oosterwijk, et al.
Pageof 13